CY2005002I2 - Χρηση της βενλαφαξινης ή μιας ενωσης αρυλοξυ προπαναμινης για την παρασκευη ενος φαρμακου για την αγωγη της ουρικης ακρατειας - Google Patents
Χρηση της βενλαφαξινης ή μιας ενωσης αρυλοξυ προπαναμινης για την παρασκευη ενος φαρμακου για την αγωγη της ουρικης ακρατειαςInfo
- Publication number
- CY2005002I2 CY2005002I2 CY2005002C CY2005002C CY2005002I2 CY 2005002 I2 CY2005002 I2 CY 2005002I2 CY 2005002 C CY2005002 C CY 2005002C CY 2005002 C CY2005002 C CY 2005002C CY 2005002 I2 CY2005002 I2 CY 2005002I2
- Authority
- CY
- Cyprus
- Prior art keywords
- venlafaxin
- aryloxy
- medication
- preparation
- treatment
- Prior art date
Links
- -1 PROPANAMINE COMPOUND Chemical class 0.000 title 1
- 206010046543 Urinary incontinence Diseases 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- PNVNVHUZROJLTJ-UHFFFAOYSA-N venlafaxine Chemical compound C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 PNVNVHUZROJLTJ-UHFFFAOYSA-N 0.000 title 1
- 229960004688 venlafaxine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15812193A | 1993-11-24 | 1993-11-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CY2005002I1 CY2005002I1 (el) | 2010-07-28 |
| CY2005002I2 true CY2005002I2 (el) | 2010-07-28 |
Family
ID=22566762
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY0100037A CY2245B1 (en) | 1993-11-24 | 2001-11-14 | Treatment of incontinence with venlafaxine or an aryloxy propanamine compound |
| CY2005002C CY2005002I2 (el) | 1993-11-24 | 2005-02-10 | Χρηση της βενλαφαξινης ή μιας ενωσης αρυλοξυ προπαναμινης για την παρασκευη ενος φαρμακου για την αγωγη της ουρικης ακρατειας |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY0100037A CY2245B1 (en) | 1993-11-24 | 2001-11-14 | Treatment of incontinence with venlafaxine or an aryloxy propanamine compound |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US5744474A (el) |
| EP (1) | EP0654264B1 (el) |
| JP (1) | JP3681009B2 (el) |
| KR (1) | KR100347277B1 (el) |
| CN (1) | CN1099284C (el) |
| AT (1) | ATE201594T1 (el) |
| AU (1) | AU679269B2 (el) |
| CA (1) | CA2136120C (el) |
| CY (2) | CY2245B1 (el) |
| CZ (1) | CZ289069B6 (el) |
| DE (2) | DE69427337T2 (el) |
| DK (1) | DK0654264T3 (el) |
| ES (1) | ES2157958T3 (el) |
| GE (1) | GEP20064000B (el) |
| GR (1) | GR3036446T3 (el) |
| HK (1) | HK1013799A1 (el) |
| HU (1) | HU218920B (el) |
| IL (1) | IL111705A (el) |
| LU (1) | LU91140I2 (el) |
| NL (1) | NL300174I2 (el) |
| NO (2) | NO313535B1 (el) |
| PH (1) | PH30741A (el) |
| PT (1) | PT654264E (el) |
| RU (1) | RU2152786C2 (el) |
| SI (1) | SI0654264T1 (el) |
| TW (1) | TW344661B (el) |
| UA (1) | UA32429C2 (el) |
| ZA (1) | ZA949190B (el) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5506270A (en) * | 1995-01-30 | 1996-04-09 | American Home Products Corporation | Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women |
| DE69721747T2 (de) * | 1996-03-11 | 2004-04-01 | Eli Lilly And Co., Indianapolis | Methode zur behandlung oder verhütung von interstitieller blasenentzundung |
| US6274171B1 (en) | 1996-03-25 | 2001-08-14 | American Home Products Corporation | Extended release formulation of venlafaxine hydrochloride |
| EP1331003B1 (en) * | 1996-03-25 | 2015-08-26 | Wyeth LLC | Extended release formulation containing venlafaxine |
| PE57198A1 (es) * | 1996-03-25 | 1998-10-10 | American Home Prod | Formula de liberacion prolongada |
| US6150396A (en) * | 1997-03-07 | 2000-11-21 | Eli Lilly And Company | Methods of treating or preventing interstitial cystitis |
| US6579899B1 (en) | 1998-07-16 | 2003-06-17 | Massachusetts Institute Of Technology | Composition for treatment of stress |
| EP1096927A4 (en) * | 1998-07-16 | 2002-09-04 | Massachusetts Inst Technology | STRESS TREATMENT COMPOSITION |
| PT1039882E (pt) * | 1998-08-27 | 2011-01-03 | Pfizer Health Ab | Formulação terapêutica para administrar tolterodina com libertação controlada |
| US6046242A (en) * | 1998-11-27 | 2000-04-04 | Basf Aktiengesellschaft | Use of aryl-substituted cyclobutylalkylamines for treating urinary incontinence |
| US6342533B1 (en) | 1998-12-01 | 2002-01-29 | Sepracor, Inc. | Derivatives of (−)-venlafaxine and methods of preparing and using the same |
| US6197828B1 (en) * | 1998-12-01 | 2001-03-06 | Sepracor, Inc. | Derivatives of (+)-venlafaxine and methods of preparing and using the same |
| ES2305606T3 (es) | 1999-04-06 | 2008-11-01 | Sepracor Inc. | Succinato de o-desmetilvenlafaxina. |
| ATE305307T1 (de) | 1999-07-01 | 2005-10-15 | Pharmacia & Upjohn Co Llc | Reboxetin zur behandlung von migränekopfschmerzen |
| US7291646B2 (en) | 1999-11-24 | 2007-11-06 | Wyeth | Ethers of O-desmethyl venlafaxine |
| US6572890B2 (en) * | 2000-01-13 | 2003-06-03 | Osmotica Corp. | Osmotic device containing venlafaxine and an anti-psychotic agent |
| DE10027290C2 (de) | 2000-06-02 | 2002-07-11 | Basf Coatings Ag | Pulverklarlackdispersionen (Pulverslurry-Klarlacke) und ihre Verwendung |
| DE10059412A1 (de) | 2000-11-30 | 2002-06-13 | Gruenenthal Gmbh | Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie der Harninkontinenz |
| EP1360169B2 (en) | 2001-02-12 | 2017-05-24 | Wyeth LLC | Succinate salt of o-desmethyl-venlafaxine |
| US6602911B2 (en) | 2001-11-05 | 2003-08-05 | Cypress Bioscience, Inc. | Methods of treating fibromyalgia |
| CN1630631A (zh) * | 2001-12-05 | 2005-06-22 | 惠氏公司 | 新的文拉法星盐酸盐多晶型物及其制备方法 |
| UA77234C2 (en) * | 2001-12-05 | 2006-11-15 | Wyeth Corp | Monohydrate of venlafaxine hydrochloride and methods for its preparation (variants) |
| GB0202265D0 (en) * | 2002-01-31 | 2002-03-20 | Arachnova Therapeutics Ltd | New therapeutic use |
| US6696496B2 (en) * | 2002-03-28 | 2004-02-24 | Synthon Bv | Low water-soluble venlafaxine salts |
| EP1499309A4 (en) * | 2002-04-24 | 2008-05-28 | Cypress Bioscience Inc | PREVENTION AND TREATMENT OF FUNCTIONAL SOMATIC DISEASES, INCLUDING STRESS-BASED DISEASES |
| DE10224107A1 (de) * | 2002-05-29 | 2003-12-11 | Gruenenthal Gmbh | Kombination ausgewählter Opioide mit anderen Wirkstoffen zur Therapie der Harninkontinenz |
| AU2003268361A1 (en) * | 2002-08-30 | 2004-03-19 | Watson Pharmaceuticals, Inc. | Drug delivery system for treating urinary incontinence |
| GB0221438D0 (en) * | 2002-09-16 | 2002-10-23 | Avecia Ltd | Processes and compounds |
| EP1424079A1 (en) * | 2002-11-27 | 2004-06-02 | Boehringer Ingelheim International GmbH | Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine |
| US20070077301A1 (en) * | 2002-12-23 | 2007-04-05 | Meyer Glenn A | Venlafaxine osmotic device formulation |
| EP1539181B1 (en) * | 2003-04-04 | 2007-06-27 | Dynogen Pharmaceuticals Inc. | Method of treating lower urinary tract disorders |
| JP4185154B2 (ja) * | 2004-04-30 | 2008-11-26 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | 中枢神経系障害治療用の置換モルホリン化合物 |
| EP2248524A3 (en) | 2004-08-25 | 2011-03-09 | Takeda Pharmaceutical Company Limited | Preventives/remedies for stress urinary incontinence and method of screening the same |
| EP1730132A2 (en) * | 2004-12-23 | 2006-12-13 | Teva Pharmaceutical Industries Ltd | Process for preparing pharmaceutically acceptable salts of duloxetine and intermediates thereof |
| TW200639162A (en) * | 2005-03-14 | 2006-11-16 | Teva Pharma | Pure duloxetine hydrochloride |
| US7842717B2 (en) | 2005-09-22 | 2010-11-30 | Teva Pharmaceutical Industries Ltd. | DNT-maleate and methods of preparation thereof |
| US7994220B2 (en) * | 2005-09-28 | 2011-08-09 | Cypress Bioscience, Inc. | Milnacipran for the long-term treatment of fibromyalgia syndrome |
| CA2631581C (en) | 2005-12-01 | 2011-05-03 | Auspex Pharmaceuticals, Inc. | Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity |
| US7759500B2 (en) | 2005-12-05 | 2010-07-20 | Teva Pharmaceutical Industries Ltd. | 2-(N-methyl-propanamine)-3-(2-naphthol)thiophene, an impurity of duloxetine hydrochloride |
| CA2629609A1 (en) | 2005-12-05 | 2007-06-14 | Wyeth | Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols |
| EP1826204A1 (en) | 2006-02-28 | 2007-08-29 | Laboratorios Del Dr. Esteve, S.A. | Process for obtaining enantiomers of duloxetine precursors |
| US20080081067A1 (en) * | 2006-10-03 | 2008-04-03 | Gupta Manishkumar | Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof |
| WO2008140859A1 (en) | 2007-03-15 | 2008-11-20 | Auspex Pharmaceuticals, Inc. | Deuterated venlafaxines and 0-desmetylvenlafaxines with serotoninergic and / or norepinephrinergic activity |
| AU2019301128B2 (en) | 2018-07-11 | 2024-07-25 | Dignify Therapeutics, Llc | Method of treating voiding dysfunction |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4314081A (en) * | 1974-01-10 | 1982-02-02 | Eli Lilly And Company | Arloxyphenylpropylamines |
| US4018895A (en) * | 1974-01-10 | 1977-04-19 | Eli Lilly And Company | Aryloxyphenylpropylamines in treating depression |
| GR75395B (el) * | 1980-11-14 | 1984-07-13 | Lilly Co Eli | |
| IE56324B1 (en) * | 1982-12-13 | 1991-06-19 | American Home Prod | Phenethylamine derivatives and intermediates therefor |
| US4761501A (en) * | 1983-10-26 | 1988-08-02 | American Home Products Corporation | Substituted phenylacetamides |
| US4956388A (en) * | 1986-12-22 | 1990-09-11 | Eli Lilly And Company | 3-aryloxy-3-substituted propanamines |
| KR880007433A (ko) * | 1986-12-22 | 1988-08-27 | 메리 앤 터커 | 3-아릴옥시-3-치환된 프로판아민 |
| PT87163B (pt) * | 1987-04-09 | 1992-07-31 | Lilly Co Eli | Processo para a preparacao de 1-fenil-3-naftaleniloxi-propanaminas |
| SE8804003D0 (sv) * | 1988-11-04 | 1988-11-04 | Pharmacia Ab | Compounds for the treatment of urinary incontinence |
| US5250571A (en) * | 1988-11-14 | 1993-10-05 | Eli Lilly And Company | (S)-norfluoxetine in method of inhibiting serotonin uptake |
| AU642582B2 (en) * | 1991-02-25 | 1993-10-21 | Eli Lilly And Company | Treatment of lower urinary tract disorders |
| US5281624A (en) * | 1991-09-27 | 1994-01-25 | Eli Lilly And Company | N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof |
| DK0537915T3 (da) * | 1991-09-27 | 1995-11-27 | Lilly Co Eli | N-alkyl-3-phenyl-3-(2-alkylthiophenoxy)propylaminer som inhibitorer for epinephrin |
| US5192751A (en) * | 1992-07-24 | 1993-03-09 | Eli Lilly And Company | Use of competitive NMDA receptor antagonists in the treatment of urinary incontinence |
-
1994
- 1994-05-12 TW TW083104298A patent/TW344661B/zh not_active IP Right Cessation
- 1994-11-18 CA CA002136120A patent/CA2136120C/en not_active Expired - Lifetime
- 1994-11-18 ZA ZA949190A patent/ZA949190B/xx unknown
- 1994-11-21 NO NO19944456A patent/NO313535B1/no not_active IP Right Cessation
- 1994-11-21 UA UA94119056A patent/UA32429C2/uk unknown
- 1994-11-21 IL IL11170594A patent/IL111705A/en not_active IP Right Cessation
- 1994-11-21 PH PH49414A patent/PH30741A/en unknown
- 1994-11-22 KR KR1019940030696A patent/KR100347277B1/ko not_active IP Right Cessation
- 1994-11-22 AT AT94308604T patent/ATE201594T1/de active
- 1994-11-22 SI SI9430379T patent/SI0654264T1/xx unknown
- 1994-11-22 DE DE69427337T patent/DE69427337T2/de not_active Expired - Lifetime
- 1994-11-22 ES ES94308604T patent/ES2157958T3/es not_active Expired - Lifetime
- 1994-11-22 JP JP28811994A patent/JP3681009B2/ja not_active Expired - Lifetime
- 1994-11-22 EP EP94308604A patent/EP0654264B1/en not_active Expired - Lifetime
- 1994-11-22 PT PT94308604T patent/PT654264E/pt unknown
- 1994-11-22 DK DK94308604T patent/DK0654264T3/da active
- 1994-11-22 AU AU78968/94A patent/AU679269B2/en not_active Expired
- 1994-11-22 DE DE1994627337 patent/DE122005000005I2/de active Active
- 1994-11-23 RU RU94041950/14A patent/RU2152786C2/ru active
- 1994-11-23 CZ CZ19942893A patent/CZ289069B6/cs not_active IP Right Cessation
- 1994-11-23 HU HU9403369A patent/HU218920B/hu unknown
- 1994-11-23 CN CN94118993A patent/CN1099284C/zh not_active Expired - Lifetime
-
1995
- 1995-04-20 US US08/425,703 patent/US5744474A/en not_active Expired - Lifetime
-
1998
- 1998-12-23 HK HK98115196A patent/HK1013799A1/xx not_active IP Right Cessation
-
2001
- 2001-08-27 GR GR20010401296T patent/GR3036446T3/el unknown
- 2001-11-14 CY CY0100037A patent/CY2245B1/xx unknown
-
2005
- 2005-02-04 LU LU91140C patent/LU91140I2/fr unknown
- 2005-02-09 NO NO2005004C patent/NO2005004I1/no unknown
- 2005-02-10 CY CY2005002C patent/CY2005002I2/el unknown
- 2005-02-10 NL NL300174C patent/NL300174I2/nl unknown
-
2006
- 2006-05-23 GE GEAP20069411A patent/GEP20064000B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2005002I2 (el) | Χρηση της βενλαφαξινης ή μιας ενωσης αρυλοξυ προπαναμινης για την παρασκευη ενος φαρμακου για την αγωγη της ουρικης ακρατειας | |
| EE9700267A (et) | a1L- agonistide kasutamine uriiniinkontinentsuse raviks | |
| DE69416451D1 (de) | Strahlenundurchlässiger Katheter | |
| HK1005425A1 (en) | Use of 2-(3,4-dimethoxycinnamoyl)-aminobenzoic acid for the manufacture of a medicament for the treatment of restenosis | |
| DE69408640D1 (de) | Wegwerfwindel | |
| DE59407363D1 (de) | Wegwerfwindel | |
| DE69406333D1 (de) | Kathetereinführungvorrichtung mit gekerbter Spritze | |
| DE69411053D1 (de) | Wegwerfwindeln | |
| NO944047D0 (no) | Strömningsledet kateter | |
| DE69429578D1 (de) | Chirurgischer strumpf | |
| DE69425531D1 (de) | Vaskulärer Katheter | |
| DE69433144D1 (de) | Wegwerfwindel | |
| DK0606164T3 (da) | Aflangt kateter | |
| DK0501705T3 (da) | Anvendelse af tomoxetin til behandling af sygdomme i de nedre urinveje | |
| EP0467564A3 (en) | Treatment of inflammatory diseases with 15-keto-prostaglandin compounds | |
| AU3728095A (en) | Use of zaprinast for the manufacture of a medicament for inhibiting vascular restenosis | |
| BR9406092A (pt) | Cateter | |
| EP0423943A3 (en) | Use of collagenase inhibitors in the treatment of demyelinating diseases, in particular multiple sclerosis | |
| FI943871A (fi) | Pidätyskyvyttömyyssuoja | |
| NO993627D0 (no) | Anvendelse av en forbindelse for fremstilling av et legemiddel | |
| GB9113776D0 (en) | Urinary catheter | |
| PT866699E (pt) | Utilizacao de inibidores de colinesterase para o fabrico de um medicamento para o tratamento de xerostomia | |
| DE59403515D1 (de) | Sprunggelenksbandage | |
| PT101618A (pt) | Proceso de fabricacao de um tecido elastico lavrado | |
| GB9324852D0 (en) | A medicament for the treatment of metasteses |